02591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.60
−0.14%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- -0.74x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.29x
- Net debt / EBITDA
- 1.32x
Liquidity & coverage
- Current ratio
- 3.50x
- Quick ratio
- 3.15x
- Cash ratio
- 2.96x
- Interest coverage
- -126.76x
- EBITDA / interest
- -125.06x
- Working capital
- HKD 1.0B
Cash & dividend
- FCF / debt
- -3.55x
- Cash flow / debt
- -3.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026